genome analysis Sophia Genetics Q2 Revenue Grows 72 Percent In its first quarterly report as a public company, Sophia reported a net loss of $18.4 million, in part due to higher expenses related to its July IPO. Sema4, Avera Health Collaborate on Precision Oncology Program The partnership, which will start with oncology, will introduce Sema4's genomic testing and Centrellis health intelligence technology to Avera's clinical and research programs. AbbVie, Biogen, Pfizer Join With Broad Institute on Genebass Exome Variant Project Premium The biopharma companies are looking to accelerate the completion of UK Biobank Exome Sequencing Consortium data analysis to aid drug discovery. Sophia Genetics Raises $234M in IPO, Eyes Additional Partnerships The stock opened at $18 per share, valuing the Switzerland- and Boston-based bioinformatics company at $1.14 billion. Sophia Genetics Increases IPO Target to $221M The company will now offer 13 million common shares at $17 to $19 per share, raising its proceeds target from the previously announced $100 million. Jun 22, 2021 Leidos Wins CDC Bioinformatics Contract Worth up to $13M Jun 14, 2021 Celemics, Strand Life Sciences Partner on Integrated Platform for NGS Analysis Jun 8, 2021 Oracle Makes Inroads in Genomic Cloud Computing Premium Jun 1, 2021 Euformatics Expands Latin American Presence With A&C Group Distribution Deal May 17, 2021 Oxford, Oracle Partner to Improve Identification of SARS-CoV-2 Variants May 6, 2021 NantHealth Q1 Revenues Decline 11 Percent Apr 12, 2021 Sanford Health Looks to Improve Rare Disease Dx, Research With Congenica Technology Premium Apr 5, 2021 Acuity Spatial Genomics to Develop Platform for In Situ Analysis of 3D Genome Organization Premium Mar 31, 2021 Rosalind, Formerly OnRamp Bio, Pushes Into Single-Cell Analysis, SARS-CoV-2 Variant Monitoring Premium Mar 30, 2021 Enpicom, Viroclinics-DDL Expand Partnership to Accelerate Antibody, Vaccine Discovery Mar 17, 2021 Genomics Plc Looks to Grow 'Genomic Prevention' With Polygenic Risk Scores Premium Mar 15, 2021 Congenica Inks French Distribution Deal With AmpliTech Mar 2, 2021 Genomics Plc Closes $30M Funding Round Feb 25, 2021 NantHealth Q4 Revenues Flat From Year Ago Feb 23, 2021 BC Platforms, Genomenon Team on Analytics for Rare Disease Dx, Research Feb 19, 2021 NRGene Looks to Royalty-Based Partnerships in Wake of IPO Premium Feb 9, 2021 UK Startup Gabriel Precision Oncology Leans on Congenica to Broaden NGS Use in Cancer Testing Premium Feb 2, 2021 Congenica, Gabriel Precision Oncology Partner on Clinical Interpretation for Somatic Cancer Testing Jan 27, 2021 GATC Health, Liquid Biosciences Partner to Provide Multiomic Biomarker Discovery Jan 21, 2021 Microsoft Brings Scalability, Apps to Broad and Verily's Terra Bioinformatics Platform Premium Load More Breaking News IV BioHoldings Partners With P4 Diagnostix, Unveils 'Bio Innovation Studio' Polynesian Island Population History Revealed From Present-Day Human Genomes Aviv Scientific Closes $40M Series B Financing Round Roche Nabs CE Mark for Three Cobas Respiratory Test Panels Hexagon Bio Raises $61M in Private Financing Round GenXys, Helix Partner to Provide Clinical Decision Support for PGx Testing The Scan Not Yet a Permanent One NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials. Unfair Targeting Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases. Limited Rapid Testing The New York Times wonders why rapid tests for COVID-19 are not widely available in the US. Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.